Market Cap 37.91M
Revenue (ttm) 0.00
Net Income (ttm) -9.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 360,700
Avg Vol 856,188
Day's Range N/A - N/A
Shares Out 15.47M
Stochastic %K 40%
Beta 0.37
Analysts Strong Sell
Price Target $8.17

Company Profile

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgi...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 322 1602
Address:
103 Carnegie Center, Suite 300, Princeton, United States
deweyeggbert
deweyeggbert Jun. 2 at 2:23 PM
$GRCE great place to buy. Caught in sector dump. Low vol. It'll bounce.
0 · Reply
demarco4ever
demarco4ever Jun. 2 at 11:18 AM
$GRCE 30% , but now
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 1 at 4:52 PM
$CING Ah, finally caught up on the @Steve_TheBull_Rogers talk. He sure is playing up that 9 for 9 on PDUFAs.. considering they were some of the most obvious plays that have happened this year. I will give him credit, $GRCE was a coin flip, that was always going to come down to CMC issues... And he picked the right side of the coin. Other than that, anybody who hadn't been lobotomized probably made the exact same picks. I'm long here, with a hedge of course, and see a very possible outcome, where no matter what happens (approval, or CRL), the share price goes up. (Especially when I know there's eight figures worth of support.)
3 · Reply
zed_rickel
zed_rickel May. 31 at 10:04 PM
$GRCE I'm just here for the offering pump
0 · Reply
D541
D541 May. 29 at 8:00 PM
$GRCE moon
0 · Reply
D3fiant
D3fiant May. 29 at 3:47 PM
$GRCE 👀tic tic tic tic You can hear it coming
0 · Reply
deweyeggbert
deweyeggbert May. 29 at 2:15 AM
$GRCE setting up for a big move.
0 · Reply
Doxtator
Doxtator May. 28 at 5:22 PM
$GRCE ...waiting is the hardest part.
0 · Reply
BB_88_
BB_88_ May. 26 at 7:50 PM
$GRCE slow and steady back over 3 in no time
0 · Reply
zed_rickel
zed_rickel May. 21 at 6:10 PM
$GRCE any ideas why the CRL hasn't been posted by the FDA yet?
1 · Reply
Latest News on GRCE
Grace Therapeutics, Inc trading resumes

2026-04-23T17:52:41.000Z - 6 weeks ago

Grace Therapeutics, Inc trading resumes


Grace Therapeutics issued Complete Response Letter from FDA

2026-04-23T17:21:26.000Z - 6 weeks ago

Grace Therapeutics issued Complete Response Letter from FDA


Grace Therapeutics, Inc trading halted, news pending

2026-04-23T16:30:22.000Z - 6 weeks ago

Grace Therapeutics, Inc trading halted, news pending


Grace Therapeutics Slides: Corporate presentation

Feb 13, 2026, 6:00 AM EST - 3 months ago

Grace Therapeutics Slides: Corporate presentation


Grace Therapeutics Earnings release: Q3 2026

Feb 12, 2026, 4:00 PM EST - 4 months ago

Grace Therapeutics Earnings release: Q3 2026


Grace Therapeutics Quarterly report: Q3 2026

Feb 12, 2026, 4:00 PM EST - 4 months ago

Grace Therapeutics Quarterly report: Q3 2026


Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year

2026-02-12T13:08:12.000Z - 4 months ago

Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year


Grace Therapeutics Slides: Corporate Presentation

Nov 30, 2025, 4:00 PM EST - 6 months ago

Grace Therapeutics Slides: Corporate Presentation


Grace Therapeutics reports Q2 EPS (6c) vs (30c) last year

2025-11-13T13:10:34.000Z - 7 months ago

Grace Therapeutics reports Q2 EPS (6c) vs (30c) last year


Grace Therapeutics Earnings release: Q2 2026

Nov 13, 2025, 7:00 AM EST - 7 months ago

Grace Therapeutics Earnings release: Q2 2026


Grace Therapeutics Quarterly report: Q2 2026

Nov 13, 2025, 7:00 AM EST - 7 months ago

Grace Therapeutics Quarterly report: Q2 2026


Grace Therapeutics secures $4M through common warrant exercises

2025-10-23T12:15:45.000Z - 8 months ago

Grace Therapeutics secures $4M through common warrant exercises


Grace Therapeutics Slides: Corporate Presentation

Aug 27, 2025, 7:00 AM EDT - 10 months ago

Grace Therapeutics Slides: Corporate Presentation


Grace Therapeutics Earnings release: Q1 2026

Aug 12, 2025, 4:00 PM EDT - 10 months ago

Grace Therapeutics Earnings release: Q1 2026


Grace Therapeutics Quarterly report: Q1 2026

Aug 12, 2025, 4:00 PM EDT - 10 months ago

Grace Therapeutics Quarterly report: Q1 2026


Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year

2025-08-12T12:10:54.000Z - 10 months ago

Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year


Grace Therapeutics Proxy statement: Proxy Filing

Jul 28, 2025, 8:00 AM EDT - 11 months ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics Proxy statement: Proxy Filing

Jul 28, 2025, 8:00 AM EDT - 11 months ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)

2025-06-23T17:01:24.000Z - 1 year ago

Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)


Grace Therapeutics Earnings release: Q4 2025

Jun 23, 2025, 7:00 AM EDT - 1 year ago

Grace Therapeutics Earnings release: Q4 2025


Grace Therapeutics Annual report: Q4 2025

Jun 23, 2025, 7:00 AM EDT - 1 year ago

Grace Therapeutics Annual report: Q4 2025


Grace Therapeutics Quarterly report: Q3 2025

Feb 12, 2025, 6:00 PM EST - 1 year ago

Grace Therapeutics Quarterly report: Q3 2025


Grace Therapeutics Earnings release: Q3 2025

Feb 12, 2025, 6:00 PM EST - 1 year ago

Grace Therapeutics Earnings release: Q3 2025


Grace Therapeutics Transcript: KOL Event

Nov 20, 2024, 2:00 PM EST - 1 year ago

Grace Therapeutics Transcript: KOL Event


Grace Therapeutics Quarterly report: Q2 2025

Nov 13, 2024, 12:00 AM EST - 1 year ago

Grace Therapeutics Quarterly report: Q2 2025


Grace Therapeutics Earnings release: Q2 2025

Nov 13, 2024, 12:00 AM EST - 1 year ago

Grace Therapeutics Earnings release: Q2 2025


Grace Therapeutics Proxy statement: Proxy Filing

Sep 6, 2024, 8:00 AM EDT - 1 year ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics Quarterly report: Q1 2025

Aug 9, 2024, 7:31 AM EDT - 1 year ago

Grace Therapeutics Quarterly report: Q1 2025


Grace Therapeutics Proxy statement: Proxy Filing

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics Annual report: Q4 2024

Jun 21, 2024, 7:00 AM EDT - 2 years ago

Grace Therapeutics Annual report: Q4 2024


Grace Therapeutics Earnings release: Q4 2024

Jun 21, 2024, 7:00 AM EDT - 2 years ago

Grace Therapeutics Earnings release: Q4 2024


Acasti Pharma to Attend BIO International Convention 2024

May 28, 2024, 4:05 PM EDT - 2 years ago

Acasti Pharma to Attend BIO International Convention 2024


Grace Therapeutics Quarterly report: Q3 2024

Feb 12, 2024, 7:00 AM EST - 2 years ago

Grace Therapeutics Quarterly report: Q3 2024


Grace Therapeutics Earnings release: Q3 2024

Feb 12, 2024, 7:00 AM EST - 2 years ago

Grace Therapeutics Earnings release: Q3 2024


Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

Feb 1, 2024, 8:00 AM EST - 2 years ago

Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial


Grace Therapeutics Quarterly report: Q2 2024

Nov 13, 2023, 7:00 AM EST - 2 years ago

Grace Therapeutics Quarterly report: Q2 2024


Grace Therapeutics Earnings release: Q2 2024

Nov 13, 2023, 7:00 AM EST - 2 years ago

Grace Therapeutics Earnings release: Q2 2024


Grace Therapeutics Proxy statement: Proxy Filing

Aug 25, 2023, 8:00 AM EDT - 3 years ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics Proxy statement: Proxy Filing

Aug 25, 2023, 8:00 AM EDT - 3 years ago

Grace Therapeutics Proxy statement: Proxy Filing


Grace Therapeutics Quarterly report: Q1 2024

Aug 11, 2023, 9:30 AM EDT - 3 years ago

Grace Therapeutics Quarterly report: Q1 2024


Grace Therapeutics Earnings release: Q1 2024

Aug 11, 2023, 9:30 AM EDT - 3 years ago

Grace Therapeutics Earnings release: Q1 2024


Acasti Pharma Announces 1-for-6 Reverse Stock Split

Jul 7, 2023, 8:00 AM EDT - 3 years ago

Acasti Pharma Announces 1-for-6 Reverse Stock Split


Acasti Pharma Reports Fiscal Year 2023 Operational Results

Jun 23, 2023, 7:00 AM EDT - 3 years ago

Acasti Pharma Reports Fiscal Year 2023 Operational Results


Grace Therapeutics Annual report: Q4 2023

Jun 23, 2023, 7:00 AM EDT - 3 years ago

Grace Therapeutics Annual report: Q4 2023


Grace Therapeutics Earnings release: Q4 2023

Jun 23, 2023, 7:00 AM EDT - 3 years ago

Grace Therapeutics Earnings release: Q4 2023


deweyeggbert
deweyeggbert Jun. 2 at 2:23 PM
$GRCE great place to buy. Caught in sector dump. Low vol. It'll bounce.
0 · Reply
demarco4ever
demarco4ever Jun. 2 at 11:18 AM
$GRCE 30% , but now
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 1 at 4:52 PM
$CING Ah, finally caught up on the @Steve_TheBull_Rogers talk. He sure is playing up that 9 for 9 on PDUFAs.. considering they were some of the most obvious plays that have happened this year. I will give him credit, $GRCE was a coin flip, that was always going to come down to CMC issues... And he picked the right side of the coin. Other than that, anybody who hadn't been lobotomized probably made the exact same picks. I'm long here, with a hedge of course, and see a very possible outcome, where no matter what happens (approval, or CRL), the share price goes up. (Especially when I know there's eight figures worth of support.)
3 · Reply
zed_rickel
zed_rickel May. 31 at 10:04 PM
$GRCE I'm just here for the offering pump
0 · Reply
D541
D541 May. 29 at 8:00 PM
$GRCE moon
0 · Reply
D3fiant
D3fiant May. 29 at 3:47 PM
$GRCE 👀tic tic tic tic You can hear it coming
0 · Reply
deweyeggbert
deweyeggbert May. 29 at 2:15 AM
$GRCE setting up for a big move.
0 · Reply
Doxtator
Doxtator May. 28 at 5:22 PM
$GRCE ...waiting is the hardest part.
0 · Reply
BB_88_
BB_88_ May. 26 at 7:50 PM
$GRCE slow and steady back over 3 in no time
0 · Reply
zed_rickel
zed_rickel May. 21 at 6:10 PM
$GRCE any ideas why the CRL hasn't been posted by the FDA yet?
1 · Reply
ClenchFists
ClenchFists May. 21 at 4:25 PM
$GRCE Time to load!! Let´s goooo
0 · Reply
Stockseeking
Stockseeking May. 21 at 3:37 PM
$GRCE List of catalysts 1. FDA meeting minutes 2. Resubmission 3. New PDUFA 4. FDA approval sp>5
0 · Reply
Stockseeking
Stockseeking May. 19 at 2:32 PM
$GRCE holding up very well considering the overall market
0 · Reply
GerdaPfuscht
GerdaPfuscht May. 19 at 2:25 PM
$GRCE any news around that type A meeting ? when is it supposed to happen ?
0 · Reply
Stockseeking
Stockseeking May. 18 at 5:32 PM
$GRCE accumulating more shares with a target of 2x within the coming 12 months.
0 · Reply
Stockseeking
Stockseeking May. 18 at 12:46 PM
$GRCE if you are long, you should be fine since after resubmission and close to the new PDUFA day, price will be 2x at the minimum. All will be within a year, which is not bad to double your investment within a year
0 · Reply
Shunbab
Shunbab May. 16 at 11:47 AM
$GRCE im out. Buying airline shares instead. GL all!!!!!
0 · Reply
deweyeggbert
deweyeggbert May. 16 at 1:41 AM
$GRCE added.
0 · Reply
Stockseeking
Stockseeking May. 15 at 7:40 PM
$GRCE holding well in such a bad day
0 · Reply
mimiwor
mimiwor May. 15 at 2:40 PM
0 · Reply
mimiwor
mimiwor May. 14 at 5:02 PM
$QUCY looking for 1000% $GRCE you are assbole.
0 · Reply
Stockseeking
Stockseeking May. 14 at 2:43 PM
$GRCE an easy double in a year after resubmission and approval, will slowly accumulate more shares along the way, no matter ups or downs
0 · Reply